[1]许崇利,许崇波,宫语晨,等.肝特异性表达hNPC1L1转基因巴马小型猪的获得[J].江苏农业学报,2017,(05):1069-1075.[doi:doi:10.3969/j.issn.1000-4440.2017.05.017]
　XU Chong-li,XU Chong-bo,GONG Yu-chen,et al.Generation of transgenic Bama minipigs with liver-specific expression of human Niemann-Pick C1-like 1(hNPC1L1)[J].,2017,(05):1069-1075.[doi:doi:10.3969/j.issn.1000-4440.2017.05.017]
点击复制

肝特异性表达hNPC1L1转基因巴马小型猪的获得()
分享到：

江苏农业学报[ISSN:1006-6977/CN:61-1281/TN]

卷:
期数:
2017年05期
页码:
1069-1075
栏目:
畜牧兽医·水产养殖
出版日期:
2017-10-30

文章信息/Info

Title:
Generation of transgenic Bama minipigs with liver-specific expression of human Niemann-Pick C1-like 1(hNPC1L1)
作者:
许崇利1; 许崇波2; 宫语晨3; 欧阳红生4
（1.吉林化工学院生物与食品工程学院，吉林吉林132022；2.韶关学院英东生命科学院，粤北生猪生产及疫病防控协同创新发展中心，广东韶关512005；3.吉林农业大学动物科学技术学院，吉林长春130118；4.吉林大学动物医学学院，吉林长春130062)
Author(s):
XU Chong-li1; XU Chong-bo2; GONG Yu-chen3; OUYANG Hong-sheng4
(1.College of Biology and Food Engineering, Jilin Institute of Chemical Technology, Jilin 132022, China;2.North Guangdong Collaborative Innovation and Development Center for Swine Farming and Disease Control, Yingdong College of Life Sciences, Shaoguan University, Shaoguan 512005, China;3.College of Animal Science, Jilin Agricultural University, Changchun 130118, China;4.College of Veterinary Medicine, Jilin University, Changchun 130062, China)
关键词:
人尼曼-匹克C1型类似蛋白1（hNPC1L1）; 肝特异性表达; 体细胞核移植; 巴马小型猪
Keywords:
human Niemann-Pick C1 like 1; liver-specific expression; somatic cell nuclear transfer; Bama miniature pig
分类号:
S858.286.5
DOI:
doi:10.3969/j.issn.1000-4440.2017.05.017
文献标志码:
A
摘要:
利用FuGENE6将线性化的pLiv-11-Neor/Kanr-hNPC1L1转染至小型猪胎儿成纤维细胞，G418筛选和PCR鉴定结果表明，成功获得了肝特异性表达人尼曼-匹克C1型类似蛋白1（Human Niemann-Pick C1 Like 1, hNPC1L1）转基因小型猪胎儿成纤维细胞。利用体细胞核移植技术将转hNPC1L1基因小型猪胎儿成纤维细胞作为核供体细胞，获得了肝特异性表达hNPC1L1转基因巴马小型猪，并对转基因巴马小型猪进行了基因组水平、转录水平和表达水平检测，同时对目的基因进行了免疫组化定位分析。结果显示，目的基因特异性地表达于肝组织，并且定位于肝小叶间胆管膜上，表明已成功获得了转hNPC1L1基因巴马小型猪，从而为研究尼曼-匹克C1型类似蛋白1 (Niemann-Pick C1 Like 1, NPC1L1)在肝中作用的分子机制提供了很好的模型动物。
Abstract:
In this study, the minipig fetal fibroblast cells with human Niemann-Pick C1-like NPC1L1 specially expressed in liver were obtained through transfecting linearized vector pLiv-11-Neor/Kanr-hNPC1L1 into minipig fetal fibroblast cell by FuGENE 6. The positive clones were selected with G418 and identified by PCR. The transgenic Bama miniature pigs with hNPC1L1 specifically expressed in the livers were generated by using somatic cell nuclear transfer technique with the minipig fetal fibroblast cells as nuclear donor cells. The transgenic Bama miniature pigs were detected on the genomic level, transcription level and expression level. Meanwhile, the target gene was analyzed by immunohistochemistry. The results showed that the target gene was specifically expressed in the liver tissue and localized on the hepatic interlobular bile duct membrane. The successful generation of hNPC1L1 transgenic Bama miniature pigs will provide a model animal for studying the molecular mechanism of NPC1L1 in liver.

参考文献/References:

[1]JOHNSON T A, PFEFFER S R. Ezetimibe-sensitive cholesterol uptake by NPC1L1 protein does not require endocytosis[J]. Molecular Biology of the Cell, 2016, 27(11): 1845-1852.
[2]PIRILLO A, L CATAPANO A, D NORATA G. Niemann-Pick C1-Like 1 (NPC1L1) inhibition and cardiovascular diseases[J]. Current Medicinal Chemistry, 2016, 23(10): 983-999.
[3]HE J, SHIN H, WEI X, et al. NPC1L1 knockout protects against colitis-associated tumorigenesis in mice[J]. BMC Cancer, 2015, 15: 189.
[4]ALTMANN S W, DAVIS H R, ZHU L, et al. Niemann-Pick C1 Like 1 protein is critical for intestinal cholesterol absorption[J]. Science, 2004, 303(5661): 1201-1204.
[5]DAVIES J P, SCOTT C, OISHI K, et al. Inactivation of NPC1L1 causes multiple lipid transport defects and protects against diet-induced hypercholesterolemia[J]. Journal of Biological Chemistry, 2005, 280(13): 12710-12720.
[6]DEUSHI M, NOMURA M, KAWAKAMI A, et al. Ezetimibe improves liver steatosis and insulin resistance in obese rat model of metabolic syndrome[J]. FEBS Letters, 2007, 581(29): 5664-5670.
[7]HUGHES E A, TRACEY I, SINGHAL S, et al. Unexpected beneficial effect in the use of ezetimibe in non-alcoholic fatty liver disease[J]. Medical Hypotheses, 2006, 67(6): 1463-1464.
[8]LABONT E D, CAMAROTA L M, ROJAS J C, et al. Reduced absorption of saturated fatty acids and resistance to diet-induced obesity and diabetes by ezetimibe-treated and Npc1l1-/- mice[J]. American Journal of Physiology-Gastrointestinal and Liver Physiology, 2008, 295(4): G776-G783.
[9]ASSY N, GROZOVSKI M, BERSUDSKY I, et al. Effect of insulin-sensitizing agents in combination with ezetimibe, and valsartan in rats with non-alcoholic fatty liver[J]. World J Gastroenterol, 2006, 12(27): 4369-4376.
[10]JAKOBSEN J E, JOHANSEN M G, SCHMIDT M, et al. Generation of minipigs with targeted transgene insertion by recombinase-mediated cassette exchange (RMCE) and somatic cell nuclear transfer (SCNT)[J]. Transgenic Research, 2013, 22(4): 709-723.
[11]DE CECCO M, SPINACI M, ZANNONI A, et al. Coupling sperm mediated gene transfer and sperm sorting techniques: a new perspective for swine transgenesis[J]. Theriogenology, 2010, 74(5): 856-862.
[12]SCOTT P A, DE CASTRO J P F, KAPLAN H J, et al. A Pro23His mutation alters prenatal rod photoreceptor morphology in a transgenic swine model of retinitis pigmentosa[J]. Investigative Ophthalmology & Visual Science, 2014, 55(4): 2452-2459.
[13]WOLF E, BRAUN-REICHHART C, STRECKEL E, et al. Genetically engineered pig models for diabetes research[J]. Transgenic Research, 2014, 23(1): 27-38.
[14]TEMEL R E, TANG W, MA Y, et al. Hepatic Niemann-Pick C1-like 1 regulates biliary cholesterol concentration and is a target of ezetimibe[J]. The Journal of Clinical Investigation, 2007, 117(7): 1968-1978.
[15]FIELD F J, WATT K, MATHUR S N. Ezetimibe interferes with cholesterol trafficking from the plasma membrane to the endoplasmic reticulum in CaCo-2 cells[J]. Journal of Lipid Research, 2007, 48(8): 1735-1745.
[16]JAKULJ L, TRIP M D, SUDHOP T, et al. Inhibition of cholesterol absorption by the combination of dietary plant sterols and ezetimibe effects on plasma lipid levels[J]. Journal of Lipid Research, 2005, 46(12): 2692-2698.
[17]BROWN W V. Cholesterol absorption inhibitors: defining new options in lipid management[J]. Clinical Cardiology, 2003, 26(6): 259-264.
[18]AHMED M H, BYRNE C D. Ezetimibe as a potential treatment for non-alcoholic fatty liver disease: is the intestine a modulator of hepatic insulin sensitivity and hepatic fat accumulation?[J]. Drug Discovery Today, 2010, 15(15/16): 590-595.
[19]YU L, BHARADWAJ S, BROWN J M, et al. Cholesterol-regulated translocation of NPC1L1 to the cell surface facilitates free cholesterol uptake[J]. Journal of Biological Chemistry, 2006, 281(10): 6616-6624.
[20]DAVIES J P, LEVY B, IOANNOU Y A. Evidence for a Niemann-Pick C (NPC) gene family: identification and characterization of NPC1L1[J]. Genomics, 2000, 65(2): 137-145.

备注/Memo

备注/Memo:
收稿日期：2016-10-18 基金项目：国家科技支撑计划项目（2011BA115B02） 作者简介：许崇利（1974-），男，黑龙江鸡东人，博士，教授，主要从事微生物分子生物学研究。（Tel）0432-62185256；（E-mail）xcl902@163.com 通讯作者：欧阳红生，（Tel）0431-87836175；（E-mail）ouyh@jlu.edu.cn
更新日期/Last Update: 2017-11-03